Aktana, a San Francisco company, specializing in decision support for life science companies, has announced the launch of its Analytics Partner Program intended to provide high-quality data sources and advanced analytics to support sales and marketing in the pharmaceutical vertical.
The program is aimed at companies that generate unique data assets focused on specialty markets or therapies, and those that perform data consolidation and standardization across multiple existing data sources.
“As pharmaceutical companies grapple with putting immense amounts of data into action, Aktana focuses on finding the nuggets of true value within,” said James Wong, vice president of product management, Aktana. “By expanding our roster of data partners and the information they provide through our platform, we can now deliver value more quickly and across even more use cases, from primary care to specialty care to oncology.”
The company’s data-sourced suggestions and insights are delivered within a sales professional’s existing CRM workflow, serving as an aid to better decision-making.
Channel Impact®
As information technology becomes more tightly interwoven with the needs of vertical markets, look for more companies to roll out such programs in support of indirect sales.
Leave a Reply